13F filer · CIK 1009258
DEERFIELD MANAGEMENT COMPANY, L.P.
New York, NY · filing since Q2 2013 · last filing Aug 14, 2026
Reported value
$9.6B
+$1.1B vs prior
Positions
82
New / sold out
13 / 13
Added / reduced
14 / 12
Turnover
10.9%
buys $980.2M · sells $1.1B
Top-10 weight
53.2%
Biggest buys vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| New | REVOLUTION MEDICINES INC | +200,000,000 | – | +$251.7M |
| Added | GENMAB A/S | +4,403,000 | +178.8% | +$121.0M |
| New | CELCUITY INC | +100,000,000 | – | +$113.8M |
| New | MINERALYS THERAPEUTICS INC | +3,958,000 | – | +$106.8M |
| New | BOSTON SCIENTIFIC CORP | +1,315,000 | – | +$56.1M |
| New | PARABILIS MEDICINES INC | +1,880,704 | – | +$51.5M |
| Added | IDEAYA BIOSCIENCES INC | +1,184,495 | +77.4% | +$44.1M |
| Added | BIOMARIN PHARMACEUTICAL INC | +481,280 | +56.5% | +$27.5M |
| New | AVALYN PHARMACEUTICALS INC | +731,000 | – | +$24.1M |
| New | ODYSSEY THERAPEUTICS INC | +1,046,139 | – | +$19.6M |
17 more rows. Subscribe for $29/month to see every row, download the data and use the API.
Biggest sells vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Sold out | MIRUM PHARMACEUTICALS INC | -70,000,000 | -100.0% | $-209.4M |
| Reduced | COGENT BIOSCIENCES INC | -4,037,799 | -44.6% | $-156.3M |
| Sold out | CATALYST PHARMACEUTICALS INC | -3,943,600 | -100.0% | $-97.6M |
| Sold out | NEUROCRINE BIOSCIENCES INC | -610,000 | -100.0% | $-80.4M |
| Sold out | DAY ONE BIOPHARMACEUTICALS I | -3,723,131 | -100.0% | $-79.8M |
| Sold out | ENHABIT INC | -4,747,746 | -100.0% | $-66.9M |
| Reduced | CENTENE CORP DEL | -1,016,091 | -17.2% | $-65.2M |
| Reduced | INSPIRE MED SYS INC | -1,406,376 | -52.0% | $-62.7M |
| Reduced | INDIVIOR PHARMACEUTICALS INC | -1,448,895 | -46.8% | $-59.4M |
| Reduced | NEOGENOMICS INC | -59,649,000 | -82.1% | $-55.8M |
15 more rows. Subscribe for $29/month to see every row, download the data and use the API.
Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.
Reported value by quarter
Holdings · Q2 2026
| # | Security | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | NUVALENT INCCOM | 17,248,450 | $2.1B | 22.22% |
| 2 | BROOKDALE SR LIVING INCNOTE 3.500%10/1 | 306,885,000 | $585.7M | 6.11% |
| 3 | REVOLUTION MEDICINES INCCOM | 2,392,000 | $448.0M | 4.67% |
| 4 | PRAXIS PRECISION MEDICINES ICOM NEW | 963,351 | $322.5M | 3.36% |
| 5 | VIATRIS INCCOM | 20,206,170 | $320.9M | 3.35% |
| 6 | CENTENE CORP DELCOM | 4,901,000 | $314.6M | 3.28% |
| 7 | REVOLUTION MEDICINES INCNOTE 0.500% 5/0 | 200,000,000 | $251.7M | 2.63% |
| 8 | UNITED THERAPEUTICS CORP DELCOM | 457,000 | $247.6M | 2.58% |
| 9 | ARROWHEAD PHARMACEUTICALS INNOTE 1/1 | 200,000,000 | $240.5M | 2.51% |
| 10 | LEGEND BIOTECH CORPSPONSORED ADS | 8,137,638 | $235.0M | 2.45% |
72 more rows. Subscribe for $29/month to see every row, download the data and use the API.